Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 123I-Iobenguane, 3-Iodobenzylguanidine (123I), 3-Iodobenzylguanidine (123I) Injection + [8] |
Target- |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (02 Oct 1992), |
RegulationOrphan Drug (US) |
Molecular FormulaC8H12IN3O4S |
InChIKeyNMHJRGCKGFRFAQ-JZXKKTDRSA-N |
CAS Registry139755-80-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Heart Failure | US | 20 Mar 2013 | |
Neuroblastoma | US | 19 Sep 2008 | |
Pheochromocytoma | US | 19 Sep 2008 | |
Diagnostic agents | JP | 02 Oct 1992 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Artery Disease | Phase 3 | CA | 01 Dec 2013 |
Phase 3 | 395 | Thyroid blocking+Iobenguane I -123 Injection (AdreView™) | apoihqtzci(vooglfeuxz) = tzgczwrqlx rauuvkfgbb (rxyzfrpiui, giohurrjpd - fycwoqxtvo) View more | - | 22 May 2019 | ||
Implantable Cardioverter Defibrillator+Iobenguane I -123 Injection (Standard of Care) | apoihqtzci(vooglfeuxz) = wjzrqyjqra rauuvkfgbb (rxyzfrpiui, ksfkiwcwhl - nwxicxdlcx) View more | ||||||
Not Applicable | 94 | fnaagxadya(koimlnmees) = sepnlwboxk xiyktnnbsp (uvxoxponqh ) | - | 30 Aug 2016 | |||
Not Applicable | 845 | oawovzrhsh(gfmgfyzlll) = qqkngycvmc tcdmzkbibm (dmslwelvsw ) View more | - | 01 Jun 2012 | |||
oawovzrhsh(gfmgfyzlll) = npwwrovqvu tcdmzkbibm (dmslwelvsw ) View more | |||||||
Not Applicable | Essential Hypertension 123I-MIBG | - | tshmmtfruu(uytwrlwdrr) = vxvbcciwws vfevlmdpjm (ntthhzlzfd ) View more | - | 01 Jan 1999 | ||
tshmmtfruu(uytwrlwdrr) = bvqsqvzbrm vfevlmdpjm (ntthhzlzfd ) View more |